The strong positivity for anti-SSA antibodies and anti-Ro-52 antibodies suggested the need to differentiate conditions such as Sjögren’s syndrome, systemic lupus erythematosus (SLE), scleroderma, and myositis, which are all rheumatic autoimmune diseases. This evidence concerns the gene TRIM21 and scleroderma.